US Broker Ratings

Glaukos Corporation (GKOS) Stock Analysis: A Medical Device Innovator with 11.32% Potential Upside

Glaukos Corporation (NYSE: GKOS), a pioneering name in the healthcare sector, specifically within the medical devices industry, is making waves with its innovative solutions targeting glaucoma, corneal disorders, and retinal..

Corcept Therapeutics (CORT) Stock Analysis: Exploring a 46% Upside Potential in the Biotech Sector

For investors seeking opportunities in the biotech sector, Corcept Therapeutics Incorporated (CORT) presents a compelling case with its current market dynamics and growth prospects. Specializing in the development of medications..

TransMedics Group, Inc. (TMDX) Stock Analysis: Exploring a 33.77% Potential Upside in Medical Device Innovation

TransMedics Group, Inc. (NASDAQ: TMDX), a pivotal player in the healthcare sector, specifically within the medical devices industry, is garnering attention with its innovative approach to organ transplant therapy. The..

Lantheus Holdings, Inc. (LNTH)

⚠️ No article content returned.

..

Krystal Biotech, Inc. (KRYS) Stock Analysis: Unveiling a Promising 14.51% Upside Potential for Investors

Krystal Biotech, Inc. (NASDAQ: KRYS), a trailblazer in the biotechnology sector, has caught the attention of investors with its focus on developing genetic medicines for conditions with significant unmet medical..

Labcorp Holdings Inc. (LH) Stock Analysis: Evaluating a 14.55% Potential Upside for Investors

Labcorp Holdings Inc. (NYSE: LH) stands as a formidable player in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Burlington, North Carolina, and boasting a market..

Align Technology, Inc. (ALGN)

⚠️ No article content returned.

..

Cytokinetics, Inc. (CYTK) Stock Analysis: A 39% Potential Upside in the Biotech Arena

Cytokinetics, Incorporated (NASDAQ: CYTK) stands as a compelling player in the biotechnology sector, primarily focusing on pioneering treatments for debilitating muscular and cardiac diseases. As the company navigates the competitive..

Ionis Pharmaceuticals (IONS): Investor Outlook on a Biotech Innovator with 27.76% Potential Upside

Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) stands out as a compelling player in the biotechnology sector, promising significant potential upside for investors intrigued by its innovative pipeline of RNA-targeted medicines. With..

RadNet, Inc. (RDNT) Investor Outlook: A 52.96% Upside Potential with Strong Buy Ratings

RadNet, Inc. (NASDAQ: RDNT) presents a compelling opportunity for investors with its robust position in the healthcare sector, specifically within the diagnostics and research industry. Headquartered in Los Angeles, California,..

Exact Sciences Corporation (EXAS) Investor Outlook: Analyzing the Growth Potential and Analyst Consensus

Exact Sciences Corporation (NASDAQ: EXAS) has positioned itself as a significant player in the healthcare sector, specifically within the diagnostics and research industry. With a market capitalization of $20.03 billion,..

Madrigal Pharmaceuticals, Inc. (MDGL) Stock Analysis: 26% Potential Upside Fuels Investor Interest

Madrigal Pharmaceuticals, Inc. (NASDAQ: MDGL) is capturing the spotlight in the biotechnology sector with its promising therapeutic developments and substantial growth potential. As a leading player in the healthcare sector,..

GSK plc (GSK): Investor Outlook Shows Modest Upside Amid Strong Revenue Growth

GSK plc (GSK) stands as a stalwart in the healthcare sector, specializing in drug manufacturing. With a market capitalization of $117.55 billion, GSK is a formidable player in the global..

Integer Holdings Corporation (ITGR)

⚠️ No article content returned.

..

ADMA Biologics Inc (ADMA) Stock Analysis: Exploring an 86% Potential Upside in the Biotechnology Sector

ADMA Biologics Inc (NASDAQ: ADMA), a biopharmaceutical company specializing in plasma-derived biologics, is capturing investor attention with a compelling potential upside of 86.19%. With a current market capitalization of $2.62..

Grifols, S.A. (GRFS) Stock Analysis: Exploring a 26.86% Upside Potential in the Healthcare Sector

Grifols, S.A. (GRFS), a prominent player in the healthcare sector, stands out with a potential upside of 26.86%, attracting the attention of savvy investors. Headquartered in Barcelona, Spain, Grifols operates..

ICON plc (ICLR) Stock Analysis: Potential Upside with Strategic Global Reach Captivates Investors

ICON plc (NASDAQ: ICLR), a prominent player in the healthcare sector, is making waves in the diagnostics and research industry. With its headquarters in Dublin, Ireland, ICON specializes in providing..

Vaxcyte, Inc. (PCVX) Investor Outlook: A Deep Dive into Its 74.82% Upside Potential

Vaxcyte, Inc. (NASDAQ: PCVX) is making waves in the biotechnology sector with its promising pipeline of vaccines aimed at combating bacterial infectious diseases. As a clinical-stage vaccine innovation company, Vaxcyte..

Soleno Therapeutics, Inc. (SLNO) Stock Analysis: Navigating the Biotech with a $2.73 Billion Market Cap and Promising Rare Disease Focus

Soleno Therapeutics, Inc. (NASDAQ: SLNO) is making waves in the biotechnology sector with a market capitalization of $2.73 billion. Based in Redwood City, California, this biopharmaceutical company is dedicated to..

McKesson Corporation (MCK) Stock Report: Analyst Ratings Signal a 14.46% Upside

Investors eyeing the healthcare sector might find McKesson Corporation (NYSE: MCK) an intriguing prospect. As a leading player in medical distribution, McKesson is a cornerstone in the healthcare supply chain,..

Search

Funds

US Broker Ratings

Search

Funds

US Broker Ratings

FTSE 100

Funds